Pharmacy Times

JULY 9, 2025

While no new adverse reactions were observed in this study, higher rates of hypersensitivity and infusion-related reactions were observed.

Labelling 26

Labelling Pharmacy Technician Compounding Pharmacies Independent Pharmacies 26

FDA Law Blog: Biosimilars

APRIL 7, 2025

Further, information presented on the adverse reaction data was inconsistent with the PI. The Warning Letter alleged that the veterinarian product website made claims about a Vaccine Safety Study relied upon for approval that directly conflict with the PI. that it is effective on Day 1) and insinuating misleading comparative claims.

Vaccines 65

Vaccines Adverse Reactions 65

Pharmaceutical Technology

JULY 7, 2025

The most common adverse reactions are diarrhoea, nausea, vulvovaginal candidiasis, genital pruritus and headache. . “Pivya will further enhance Alembic’s ability to build long-term value by combining global research, regulatory and manufacturing strengths with a sharpened focus on speciality segments.

Packaging 52

Packaging Adverse Reactions Communication Hospitals 52

The Thyroid Pharmacist

MARCH 7, 2025

An adverse reaction to mold can be a trigger for Hashimotos, asthma, and other autoimmune conditions. [23] Some molds produce toxic secondary metabolites called mycotoxins. We call these toxic molds, as their mycotoxins can cause serious health problems for both humans and animals.

Health and Personal Care Stores 67

Health and Personal Care Stores Labelling Immunization Immunity 67

FDA Law Blog: Biosimilars

JUNE 4, 2025

This Assessment suggests causation may be viewed using a different standard moving forward, leading to the inclusion of additional information in the Warnings and Precautions or Adverse Reactions sections of drug labeling, or other potential consequences.

Labelling 59

Labelling Adverse Reactions Vaccines Documentation 59

Pharmacy Times

JULY 18, 2025

1,2 The most common adverse reactions are abdominal pain, diarrhea, dizziness, flatulence, headache, nausea, soft feces, vomiting, and vulvovaginal candidiasis. The use of gepotidacin in pregnancy and breastfeeding has not been evaluated. It has not been studied in patients younger than 12 years or who weigh less than 40 kg.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Pharmacy Management Adverse Reactions 26

The Pharmacist

MAY 26, 2023

Known as the Yellow Card biobank, the biobank will contain genetic data and patient samples and be used by scientists […] The post Adverse reactions biobank to launch next month appeared first on The Pharmacist.

Adverse Reactions 98

Adverse Reactions 98

STAT

MAY 9, 2023

It turns out that one of the supplements recommended by the health coach has adverse reactions with a medication prescribed by his doctor. He goes to the emergency room, where they immediately ask him about medications and supplements he’s taking. The health coach never asked John about his medications. Read the rest…

Adverse Reactions 251

Adverse Reactions Hospitals 251

STAT

JANUARY 31, 2024

and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address. Experts say that the Singulair incident highlights a flawed system, both in the U.S. “The question is, how safe do you want to be?”

Adverse Reactions 285

Adverse Reactions Labelling Hospitals 285

Pharma Times

FEBRUARY 15, 2024

CLM-HT01 improved blood pressure and minimised adverse reactions in patients

Adverse Reactions 166

Adverse Reactions 166

ALiEM - Pharm Pearls

SEPTEMBER 27, 2023

What well-known adverse reaction results from ingestion of the pictured mushroom? Acute hepatitis Disulfiram-like reaction with ethanol consumption Pneumonitis from inhalation of spores Seizures from glutamate agonist activity [Image from Canstockphoto] Reveal the Answer 2. What is the mechanism of the adverse reaction? [2-5]

Adverse Reactions 169

Adverse Reactions 169

The Pharmacist

MAY 21, 2024

The Patterns and Prevalence of Adult Food Allergy report also found that around 36% of people have a self-reported adverse reaction to food. More than one in 20 adults in the UK has a clinically confirmed food allergy, according to a detailed study commissioned by the Food Standards Agency.

Adverse Reactions 121

Adverse Reactions 121

NY Times

SEPTEMBER 8, 2020

The company halted late-stage trials of its coronavirus vaccine because of a serious suspected adverse reaction in a participant.

Adverse Reactions 98

Adverse Reactions Vaccines 98

The Pharmacist

OCTOBER 25, 2024

Healthcare professionals should also ensure patients are aware of the side-effects of the diabetes and weight loss injections and report any adverse reactions through the Yellow Card reporting scheme, the Medicines and Healthcare […] The post MHRA urges pharmacists to be alert to signs of GLP-1 RA ‘misuse’ appeared first on The Pharmacist.

Adverse Reactions 93

Adverse Reactions Diabetes 93

Express Pharma

JANUARY 16, 2024

“It is a known adverse reaction of many drugs…When prescribing any medicine, doctors take patient history and other individual factors into account to reduce the risk of any adverse reaction,” the statement said.

Adverse Reactions 105

Adverse Reactions Documentation 105

Pharmaceutical Technology

MAY 19, 2023

Blurred vision and eye redness are the most common adverse reactions observed with Miebo. The two 57-day, double-masked, multi-centre, saline-controlled, randomised trials were conducted in 1,217 people with DED history and clinical signs of Meibomian gland dysfunction, a major cause of development and disease progression.

Adverse Reactions 133

Adverse Reactions 133

Pharmacy Times

JULY 5, 2024

Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.

Adverse Reactions 26

Adverse Reactions 26

pharmaphorum

DECEMBER 9, 2020

The most common adverse reactions seen in a trial cohort of 38,000 patients were at injection sites (84.1%) followed by fatigue (62.9%) and headache (55.1%), and serious adverse reactions occurred in 0% to 4.6% of participants.

Vaccines 111

Vaccines Adverse Reactions Documentation Immunization 111

European Pharmaceutical Review

NOVEMBER 21, 2022

The most common adverse reactions (ARs) in 10 percent or more of patients were respiratory tract infection (RTI), viral infection, diarrhoea, dyspepsia, cough, arthralgia, arthritis and peripheral edema. Serious adverse reactions (SARs) were reported in 13 percent (3/24) of patients who received the mAb.

Adverse Reactions 111

Adverse Reactions Labelling 111

Pharmaceutical Business Review

AUGUST 8, 2024

Common adverse reactions include feeling hot, dizziness, headache, nausea, palpitations, chills, vomiting, allodynia, tinnitus, ear discomfort, burning sensation, hot flush, feeling abnormal, and irritability.

Adverse Reactions 105

Adverse Reactions 105

European Pharmaceutical Review

JANUARY 18, 2023

To date, most solicited adverse reactions were mild or moderate. The most commonly reported solicited adverse reactions in the mRNA-1345 group were injection site pain, fatigue, headache, myalgia, and arthralgia. The trial showed the mRNA vaccine was well tolerated with no safety concerns identified.

Vaccines 105

Vaccines Adverse Reactions 105

Pharmacy Times

JANUARY 4, 2024

This study showed the importance of a multidisciplinary team’s expertise to investigate a clinical inquiry beyond the scope of the clinicians’ skillset and their access to necessary technology.

Adverse Reactions 36

Adverse Reactions 36

European Pharmaceutical Review

OCTOBER 18, 2023

However, in the trials, the only observed adverse reaction for the treatment was diarrhoea. Overall, the data showed that XPHOZAH significantly reduced elevated serum phosphorus in patients receiving maintenance hemodialysis.

Adverse Reactions 119

Adverse Reactions Labelling 119

Pharmacy Times

JUNE 20, 2023

A counterfeit medication was reportedly purchased at a retail pharmacy, appearing to have contained another type of diabetes medication that led to an adverse reaction.

Adverse Reactions 62

Adverse Reactions Diabetes 62

pharmaphorum

SEPTEMBER 10, 2020

That could be important if it takes longer than expected to bring vaccines and antibodies to market, said a spokesman for the companies, pointing to the news this week that AstraZeneca has halted phase 3 trials of its COVID-19 vaccine candidate AZD1222 after a serious adverse reaction in one patient.

Vaccines 133

Vaccines Adverse Reactions Immunity Immunization 133

Express Pharma

JULY 16, 2024

This new system uses an ionic buffer blend to keep ophthalmic solutions sterile while reducing adverse reactions, providing a safer and more effective option for long-term eye care. The EyeBS preservative system is a major advancement in ophthalmic care, formulated with borate, sorbitol, propylene glycol, and zinc.

Adverse Reactions 94

Adverse Reactions 94

LifeProNow

MARCH 10, 2023

The most common adverse reactions reported in at least 2% of patients treated with ZAVZPRET and at a frequency greater than placebo were taste disorders (includes dysgeusia and ageusia), nausea, nasal discomfort and vomiting. If a hypersensitivity reaction occurs, discontinue ZAVZPRET and initiate appropriate therapy.

Adverse Reactions 100

Adverse Reactions 100

Pharmaceutical Technology

MAY 23, 2023

Dizziness, flushing, eye oedema and peripheral oedema are the most common adverse reactions for Ayvakit. Ayvakit showed improvements in disease symptoms and measures of mast cell burden compared to placebo. The company is now offering Ayvakit at a recommended 25mg once-a-day dose for adults with ISM.

Adverse Reactions 98

Adverse Reactions Labelling 98

European Pharmaceutical Review

NOVEMBER 23, 2022

The most common adverse reactions (AR) associated with Hemgenix included liver enzyme elevations (transaminitis), headache, mild infusion-related reactions and flu-like symptoms. Patients should be monitored for adverse infusion reactions and transaminitis in their blood.

Adverse Reactions 128

Adverse Reactions 128

Pharmaceutical Technology

JULY 6, 2022

Tenderness/pain at the injection site, headache, myalgia, fatigue and malaise were the most common adverse reactions reported. Furthermore, the vaccine was found to be well-tolerated in the initial safety findings from the study.

Vaccines 105

Vaccines Adverse Reactions 105

Pharmaceutical Technology

DECEMBER 7, 2022

A reduced number of serious and severe adverse reactions (AR) were reported and balanced between the vaccine and placebo arms. . Effectiveness was backed by clinical efficacy showing that the vaccine offered an overall 79.5% clinical protective efficacy when the Delta variant of the virus was prevalent.

Vaccines 105

Vaccines Adverse Reactions 105

Pharmaceutical Technology

NOVEMBER 25, 2022

Nausea, fatigue, vomiting, reduced neutrophil count, alopecia and anaemia among others were observed to be the most prevalent adverse reactions. The safety profile of Enhertu in this trial was in line with those seen in prior studies without any new safety concerns reported.

Adverse Reactions 105

Adverse Reactions Chemotherapy Labelling 105

Pharmaceutical Technology

FEBRUARY 20, 2023

Vitreous floaters, ocular discomfort, conjunctival hemorrhage, and neovascular AMD were the most common adverse reactions observed in patients receiving Syfovre. Syfovre’s safety profile is well-demonstrated after approximately 12,000 injections over 24 months.

Adverse Reactions 98

Adverse Reactions Immunization Immunity 98

Pharmaceutical Technology

MARCH 1, 2023

Rash pruritic, leukopenia, myalgia, injection site pruritus, neutropenia, fatigue, and constipation were the typical adverse reactions observed in the patients treated with Kevzara. The trial met its primary endpoint, with 28% of patients treated with Kevzara achieving sustained remission compared to 10% for placebo at 52 weeks.

Adverse Reactions 98

Adverse Reactions 98

European Pharmaceutical Review

NOVEMBER 13, 2023

In these clinical trials, the most common adverse reactions were diarrhoea, thrombocytopaenia, nausea, headache, dizziness, fatigue, asthenia, abdominal pain and cough. This trial aimed to evaluate the efficacy and safety of momelotinib versus ruxolitinib for myelofibrosis in those who had not received a prior JAK-inhibitor therapy.

Adverse Reactions 109

Adverse Reactions Pharmaceutical Companies Pharmaceutical Companies 109

PharmExec

JUNE 2, 2023

New program seeks to reduce misuse and adverse reactions by simplifying prescription labels.

Adverse Reactions 52

Adverse Reactions Labelling 52

PharmaTech

FEBRUARY 12, 2024

The agency’s safety committee stressed the risk of potential adverse reactions involved with taking Paxlovid (nirmatrelvir, ritonavir) in combination with certain immunosuppressants.

Adverse Reactions 52

Adverse Reactions 52